Skip to main content

Pneumoconiosis clinical trials at University of California Health

1 research study open to eligible people

Showing trials for
  • FAPI PET for Lung Fibrosis

    open to eligible people ages 18 years and up

    This is a prospective exploratory biodistribution study in patients with interstitial lung disease (ILD). The purpose of this research study is to determine where and to which degree the FAPI tracer (68Ga-FAPI-46) accumulates in normal and fibrotic…

    at UCLA

Our lead scientists for Pneumoconiosis research studies include .

Last updated: